Co-infection with SARS-CoV-2 and Human Metapneumovirus.
R I Med J (2013)
; 103(2): 75-76, 2020 Mar 19.
Article
in English
| MEDLINE | ID: covidwho-13511
ABSTRACT
The novel coronavirus (now called SARS-CoV-2) initially discovered in Wuhan, China, has now become a global pandemic. We describe a patient presenting to an Emergency Department in Rhode Island on March 12, 2020 with cough and shortness of breath after a trip to Jamaica. The patient underwent nasopharyngeal swab for a respiratory pathogen panel as well as SARS-CoV-2 RT-PCR. When the respiratory pathogen panel was positive for human metapneumovirus, the patient was treated and discharged. SARS-CoV-2 RT-PCR came back positive 24 hours later. Although respiratory viral co-infection is thought to be relatively uncommon in adults, this case reflects that SARS-CoV-2 testing algorithms that exclude patients who test positive for routine viral pathogens may miss SARS-CoV-2 co-infected patients.
Keywords
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Nasopharynx
/
Paramyxoviridae Infections
/
Coronavirus Infections
/
Cough
/
Metapneumovirus
/
Dyspnea
/
Betacoronavirus
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Middle aged
Language:
English
Journal:
R I Med J (2013)
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS